Gyrus Medical Limited – Trademark Portfolio

Entity Type: 99

Gyrus Medical Limited holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 22 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include PK, GYRUS, TWIZZLE, SUPERLOOP, and SUPERSECT.

Fortran Road, St Mellons

Cardiff CF3 0LT

22 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Gyrus Medical Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (22 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Gyrus Medical Limited have?

Gyrus Medical Limited has 22 U.S. trademarks filed with the USPTO. Of these, 9 registered, 4 abandoned, 8 cancelled.

What trademark classes does Gyrus Medical Limited file in?

Gyrus Medical Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Gyrus Medical Limited's most well-known trademarks?

Gyrus Medical Limited's registered trademark portfolio includes well-known marks such as PK, GYRUS, TWIZZLE, SUPERLOOP, and SUPERSECT. These are among 9 currently registered trademarks in the portfolio.

What is Gyrus Medical Limited's trademark registration success rate?

Gyrus Medical Limited has a 43% trademark registration rate, with 9 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.